Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007
- PMID: 19406247
- DOI: 10.1016/j.anaerobe.2009.04.004
Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007
Abstract
The susceptibility trends for all anaerobes processed by the Anaerobe Reference Laboratory against various antibiotics were determined by using data for 2557 isolates referred by all government hospitals in Kuwait from 2002 to 2007. MIC were determined for the following anti-anaerobic antibiotics: amoxicillin-clavulanic acid, clindamycin, imipenem, meropenem, metronidazole, penicillin, piperacillin, piperacillin-tazobactam and vancomycin (for Gram-positive anaerobes only), using E-test method. The commonest isolates were Bacteroides fragilis (36.8%), followed by Peptostreptococcus spp. (21.9%), Bacteroides ovatus (15.5%) and Prevotella bivia (12.1%). In addition, Prevotella oralis and other Bacteroides spp. represented 8.5% and 8.1% of total number of isolates, respectively. Resistance rate varied among the antimicrobial agents and the species tested. The beta-lactams, with the exception of penicillin, were the most active drugs. Piperacillin-tazobactam was the only antimicrobial agent to which all the isolates were uniformly susceptible. Imipenem and metronidazole were highly active with resistance rate of only <5% recorded against most isolates. However, 42.8, 55.8 and 9.3% of Clostridium difficile isolates were resistant to imipenem, clindamycin and meropenem, respectively. It is noteworthy that from 2002 to 2007, there was a gradual increase in resistance rates to clindamycin, amoxicillin-clavulanic acid and piperacillin among B. fragilis. Periodic surveillance of antibiotic resistance among the anaerobic bacteria is recommended as a guide to empiric antibiotic use and formulation of guideline for appropriate choice of antimicrobial therapy in anaerobic infections.
2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.J Antimicrob Chemother. 2006 May;57(5):992-8. doi: 10.1093/jac/dkl052. Epub 2006 Feb 28. J Antimicrob Chemother. 2006. PMID: 16507560
-
Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data.Anaerobe. 2015 Feb;31:25-30. doi: 10.1016/j.anaerobe.2014.08.012. Epub 2014 Sep 2. Anaerobe. 2015. PMID: 25193745
-
Susceptibility of anaerobic bacteria in Auckland: 1991-1996.N Z Med J. 1999 Nov 12;112(1099):424-6. N Z Med J. 1999. PMID: 10678225
-
[The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].Schweiz Rundsch Med Prax. 1991 Dec 27;80(52):1474-80. Schweiz Rundsch Med Prax. 1991. PMID: 1815309 Review. German.
-
In vitro activity of ertapenem: review of recent studies.J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204. J Antimicrob Chemother. 2004. PMID: 15150179 Review.
Cited by
-
Antimicrobial Susceptibility Patterns and Wild-Type MIC Distributions of Anaerobic Bacteria at a German University Hospital: A Five-Year Retrospective Study (2015-2019).Antibiotics (Basel). 2020 Nov 18;9(11):823. doi: 10.3390/antibiotics9110823. Antibiotics (Basel). 2020. PMID: 33217968 Free PMC article.
-
Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeri in an immunocompetent adult: a case report and literature review.BMC Infect Dis. 2012 Jul 20;12:161. doi: 10.1186/1471-2334-12-161. BMC Infect Dis. 2012. PMID: 22817336 Free PMC article. Review.
-
In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.Antibiotics (Basel). 2022 Feb 22;11(3):292. doi: 10.3390/antibiotics11030292. Antibiotics (Basel). 2022. PMID: 35326756 Free PMC article.
-
Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial.Front Med (Lausanne). 2022 Aug 3;9:888186. doi: 10.3389/fmed.2022.888186. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35991648 Free PMC article.
-
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.J Antimicrob Chemother. 2013 Oct;68(10):2369-74. doi: 10.1093/jac/dkt191. Epub 2013 May 21. J Antimicrob Chemother. 2013. PMID: 23696621 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous